Filing metadata

Accession number
0000947871-22-000125
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Feb 01, 2022
Reporting period
Feb 01, 2022
Description
Insider transaction

Explore SEC Filings Hub